PET-CT in Lymphoma Among the Eldery
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age60+
SponsorAssiut University
About this trial
This study investigates PET-CT imaging patterns and metabolic parameters in elderly patients (≥60 years) diagnosed with lymphoma, aiming to enhance diagnostic accuracy and prognosis using 18F-FDG PET/CT scans.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
The participants include elderly patients (≥60 years) with confirmed lymphoma diagnosis through histopathological examination. Excluded are individuals with other active cancers or uncontrolled diabetes mellitus (blood glucose \> 200 mg/dL), which could interfere with PET scan accuracy. Patients must have fasting blood glucose \< 200 mg/dL before 18F-FDG injection and are prepared per standardized protocols. The sample size is calculated to be approximately 63 patients, providing adequate statistical power based on confidence limits and previous positive PET findings in elderly lymphoma cohorts.
Trial design
Design model
Case-only
Time perspective
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
FDG-PET/CT Imaging Pattern Description in Elderly Lymphoma Patients
The main outcome is the characterization of metabolic and anatomical findings from 18F-FDG PET/CT scans among elderly patients (≥60 years) diagnosed with lymphoma. This includes describing the visual appearance, extent, and distribution of disease lesions observed on initial imaging.
Time frame
At time of initial PET/CT scan performed as part of routine clinical evaluationLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: